GABRG2 rs10845640: Understanding This Common Genetic Variant
The rs10845640 variant is a common single nucleotide polymorphism located within the GABRG2 gene. This gene is essential for the proper function of GABA-A receptors, and research investigates how variations in this region may influence susceptibility to various epilepsy phenotypes.
What each genotype means
Typical GABRG2 profile
This genotype represents the most common sequence observed in the general population for this location in the GABRG2 gene. While GABRG2 variants are known to be associated with various epilepsy syndromes, this specific genotype is not typically linked to increased risk. Please consult with a healthcare provider if you have concerns regarding personal or family history of seizures.
This is the most common genotype found across all major global populations.
Common variant carrier
Carrying one copy of this variant is common and generally considered part of normal human genetic variation. While the GABRG2 gene is involved in GABAergic signaling and certain rare mutations in this gene are linked to epilepsy, this specific genotype does not carry a known clinical diagnosis. Discuss any specific health concerns or family history with your clinician.
This genotype is observed at varying frequencies across global populations, often present in a significant portion of the general public.
Common variant carrier
This genotype is a common variation in the GABRG2 gene and is generally not associated with clinical disease in the absence of other rare, pathogenic mutations. Research into GABRG2 focuses primarily on rare, ultra-rare, or pathogenic variants that disrupt GABA receptor function. If you have a personal or family history of epilepsy, please discuss this result with a genetic counselor or neurologist.
This genotype is found in a subset of the population, with frequencies varying by ancestral background.
What is rs10845640?
The rs10845640 variant is a specific change in the DNA sequence located within the GABRG2 gene. In genomics, an rsID (reference SNP cluster ID) acts as a unique identifier for a single nucleotide polymorphism (SNP), which is a variation at a single position in the DNA sequence. This particular variant is considered a common polymorphism, meaning it is found frequently across diverse human populations. It sits within the genomic architecture of the GABRG2 gene, which provides instructions for creating the gamma-2 subunit of the GABA-A receptor. Because this variant is common, it is often studied in the context of complex genetic traits rather than rare, single-gene disorders. Researchers use these identifiers to track how specific DNA positions correlate with biological traits or health outcomes across large cohorts.
The Role of the GABRG2 Gene
The GABRG2 gene encodes the gamma-2 subunit of the GABA-A receptor, a critical protein complex in the human brain. GABA-A receptors are the primary mediators of fast inhibitory neurotransmission, acting like a 'brake' for the nervous system to prevent over-excitation. The gamma-2 subunit is particularly important because it is required for the receptor to respond to benzodiazepines and for the proper trafficking and localization of the receptor to the postsynaptic membrane. When GABRG2 function is altered, the balance between excitation and inhibition in the brain can be disrupted. While rare, highly damaging mutations in this gene are well-documented causes of severe epilepsy syndromes, such as Dravet syndrome and genetic epilepsy with febrile seizures plus (GEFS+). Understanding how common variants like rs10845640 interact with this system is a major focus of ongoing neurological research.
Research and Evidence Strength
The evidence linking common variants in GABRG2 to epilepsy is nuanced. While rare, ultra-rare, or pathogenic mutations in GABRG2 have a strong, established causal link to specific epilepsy syndromes, the role of common variants like rs10845640 is less clear. Large-scale association studies have often found that common variants in this gene do not show a strong, independent effect on the development of common, complex forms of epilepsy. However, some research suggests that the GABRG2 locus may contribute to susceptibility for specific phenotypes, such as febrile seizures. It is important to distinguish between rare, high-impact mutations and common, low-impact polymorphisms. Current scientific consensus indicates that while the GABRG2 gene is a critical player in epilepsy, the specific contribution of common SNPs remains a subject of active investigation rather than a definitive diagnostic marker.
Population Frequency
The rs10845640 variant is classified as a common polymorphism, meaning it is present at significant frequencies across most major ancestral populations. Unlike rare variants that might be restricted to specific families or isolated groups, this SNP is widely distributed. Because it is common, it is frequently included in genome-wide association studies (GWAS) that aim to map the genetic architecture of complex traits. The frequency of the alleles (the specific DNA letters at this position) can vary slightly between populations, but it is generally stable enough to be considered a standard part of human genetic diversity. Researchers use this widespread distribution to ensure that their studies are representative of the general population, though they must always account for ancestry-specific differences when interpreting how genetic variants might influence health outcomes.
Interpreting Your Genetic Information
It is vital to understand that having a common variant like rs10845640 does not constitute a medical diagnosis. Genetic predisposition is complex, and most health traits are influenced by a combination of many genes, environmental factors, and lifestyle choices. Because the evidence for common GABRG2 variants is often mixed or shows only weak statistical associations, this information should not be used to predict personal health outcomes or make medical decisions. If you have concerns about epilepsy, seizures, or neurological health, you should consult with a neurologist or a genetic counselor. They can provide context based on your personal and family medical history, which is far more predictive than any single SNP. Never change your medication or treatment plan based on genetic data without first discussing it with your clinician or pharmacist, as they are the only ones qualified to interpret these results in a clinical context.
How common is this variant?
The rs10845640 variant is a common polymorphism found across diverse global populations, with its specific allele frequencies varying by ancestry.
Frequently asked questions
Is rs10845640 a cause of epilepsy?
No, rs10845640 is a common genetic variant and is not considered a direct cause of epilepsy. While rare, damaging mutations in the GABRG2 gene are linked to epilepsy, common variants like this one generally do not have a strong, independent effect on disease risk.
Should I be worried if I have the G allele?
No, there is no reason for concern. The G allele is a common variation found in many healthy individuals and is not a diagnostic marker for any medical condition.
Can I use this information to change my medication?
Absolutely not. You should never change your medication or treatment plan based on genetic test results. Always discuss any changes to your health management with your doctor or pharmacist.
Where can I find more information about GABRG2?
You can find reliable information about the GABRG2 gene and its role in health through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide peer-reviewed, accurate summaries of gene functions and their associations with human health.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10845640?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
This variant is associated with susceptibility to childhood absence epilepsy and febrile seizures.